OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-12-31-accounts

Trustees’ Annual Report for the period

From 01/01/2025 To

31/12/2025

Charity name: A Rare Cause Charity registration number: 1198461

Objectives and Activities

SORP reference
Summary of the purposes of
the charity as set out in its
governing document
Para 1.17 The advancement of health or the saving of
lives in relation to the global rare disease
community, in particular by providing
information and resources to raise knowledge
and increase awareness (as set out in the
charity'sgoverningdocument).
Summary of the main
activities in relation to those
purposes for the public
benefit, in particular, the
activities, projects or
services identified in the
accounts.
Para 1.17 and
1.19
During the period the charity supported
diagnostic and clinical service delivery for rare
disease patients in South Africa under a service
level agreement with Rare Diseases South
Africa; received and began administering a
major grant from Direct Relief for the LSD-
Impact programme; and undertook advocacy,
education and awareness-raising activity,
including participation in international rare
disease conferences and working groups and
patient storytellingcontent.
Statement confirming
whether the trustees have
had regard to the guidance
issued by the Charity
Commission on public
benefit
Para 1.18 The trustees confirm that they have had regard
to the Charity Commission's general guidance
on public benefit in exercising their powers and
duties, and are satisfied that the charity's aims
and activities deliver public benefit consistent
with its objects.

Additional information (optional) You may choose to include further statements where relevant about:

SORP reference
Policy on grant making Para 1.38 Grants and programme funding are made to
partner organisations delivering rare disease
diagnostic and support services overseas,
under written service level agreements, with
outcomes reported back to the trustees.
Policy on social investment
including program related
investment
Para 1.38 Not applicable – the charity does not hold
funds for social investment.
Contribution made by
volunteers
Para 1.38 Two volunteers supported the charity's
activities during the period, in addition to the
trustees.
Other

Achievements and Performance

----- Start of picture text -----
SORP reference
----- End of picture text -----

Achievements and Performance Achievements and Performance Achievements and Performance
SORP reference
Summary of the main
achievements of the charity,
identifying the difference the
charity’s work has made to
the circumstances of its
beneficiaries and any wider
benefits to society as a
whole.
Para 1.20 The charity secured and began administering a
significant grant from Direct Relief in support
of its Lysosomal Storage Disease (LSD)-Impact
rare disease programme, and continued to
fund diagnostic support delivered in South
Africa through its partner, Rare Diseases South
Africa. Trustees and representatives
strengthened ARC's international standing
through participation in the International Rare
Diseases Consortium Assembly (IRDiRC), the
International Working Group on Gaucher
Disease and the International MPS Society
meeting, and through webinars with Rare
Disease International, the African Society for
Laboratory Medicine and other partners. Work
also began on a flagship African-focused
Gaucher disease/iPSC research initiative, and
the charity's public advocacy and patient-
storytelling activity (including a documentary
on MPS I) extended its reach as a credible voice
on rare disease andglobal health equity.

Additional information (optional) You may choose to include further statements where relevant about:

Achievements against
objectives set
Para 1.41 Diagnostic support in South Africa continued
under the service level agreement with Rare
Diseases South Africa, and the charity began
work on developing the first African-derived
iPSC models for Gaucher disease research, in
collaboration with academic partners in the
USA.
Performance of fundraising
activities against objectives
set
Para 1.41 The charity received a major grant from Direct
Relief for the LSD-Impact programme and
initiated a grant application to the Michael J.
Fox Foundation to fund a two-year
postdoctoral research role supporting the
Gaucher/iPSC initiative.
Investment performance
against objectives
Para 1.41 Not applicable – the charity does not hold an
investment portfolio; funds are held as cash.

Financial Review

----- Start of picture text -----
Review of the charity’s Para 1.21 Total income for the period was £25,372 (2024:
financial position at the end £120), principally a grant of £25,342 from
of the period Direct Relief together with £30 of donations.
Total spending was £2,007, including £552
spent on the charity's programme in South
Africa (of which £502 was paid as a grant to
Rare Diseases South Africa) and the balance on
administration, travel and banking costs. The
charity held cash funds of £23,485.49 at 31
December 2025 (2024: £120), all as
unrestricted funds.
Statement explaining the Para 1.22 The trustees aim to hold reserves sufficient to
policy for holding reserves cover the charity's core running costs and
stating why they are held committed programme spend, noting that the
majority of funds held at the year end are
earmarked for the LSD-Impact programme.
Amount of reserves held Para 1.22 Total cash held was £23,485.49 at the year end,
the majority of which is committed to the LSD-
Impact programme.
Reasons for holding zero Para 1.22 Not applicable – the charity held cash reserves
reserves at the year end.
Details of fund materially in Para 1.24 None.
deficit
Explanation of any Para 1.23 The trustees have no material uncertainties
uncertainties about the about the charity's ability to continue as a
charity continuing as a going going concern.
concern
----- End of picture text -----

Additional information (optional)
You may choose to include further statements
Additional information (optional)
You may choose to include further statements
where relevant about:
The charity’s principal
sources of funds (including
any fundraising)
Para 1.47 The charity's funds are principally derived from
grants from international foundations and
NGOs (including Direct Relief) and from
individual donations.
Investment policy and
objectives including any
social investment policy
adopted
Para 1.46 The charity does not hold an investment
portfolio. Funds not immediately required are
held as cash with Wise Payments Ltd and, from
2026, CAF Bank.
A description of the principal
risks facing the charity
Para 1.46 The principal risks identified by the trustees
are: reliance on a small number of grant
funders and the risk of funding not being
renewed; foreign exchange and payment-
transfer risk on funds sent to support overseas
programmes; and the capacity of a small,
wholly volunteer trustee board to manage
growth in the charity's activities.

Structure, Governance and Management

Description of charity’s
trusts:
Type of governing document
(trust deed, royal charter)
Para 1.25 Constitution (Charitable Incorporated
Organisation – Foundation model), registered
with the Charity Commission on 31 March
2022.
How is the charity
constituted?
(e.g unincorporated
association, CIO)
Para 1.25 A Rare Cause is constituted as a Charitable
Incorporated Organisation (CIO) – Foundation
model.
Trustee selection methods
including details of any
constitutional provisions e.g.
election to post or name of
any person or body entitled
to appoint one or more
trustees
Para 1.25 Trustees are appointed by the existing trustees
in accordance with the charity's constitution.

Additional information (optional) You may choose to include further statements where relevant about:

Policies and procedures
adopted for the induction
and training of trustees
Para 1.51 During the year, the trustees developed,
reviewed and formally adopted policies
covering bullying and harassment,
international financial controls, risk
management, and safeguarding. These policies
are intended to support appropriate
governance, oversight, and protection of the
charity, its beneficiaries, volunteers, and other
stakeholders.
The charity’s organisational
structure and any wider
network with which the
charity works
Para 1.51 The charity is governed by a board of trustees
(four trustees during the period) and has no
employees; day-to-day activity is carried out by
trustees and volunteers.
Relationship with any
related parties
Para 1.51 No related party transactions were identified
during the period; grant recipients were not
related parties to the charity.

Reference and Administrative details

----- Start of picture text -----
Charity name A Rare Cause
Other name the charity uses ARC
Registered charity number 1198461
Charity’s principal address 6 The Green, Ilkley, LS29 7FF
----- End of picture text -----

Names of the charity trustees who manage the charity

----- Start of picture text -----
Nam
e of
pers
on
(or
body
Dates acted if not for whole )
Trustee name Office (if any)
year entitl
ed to
appo
int
trust
ee (if
any)
1 Prof Amaka Offiah Whole year
2 Dr Dumebi Oderinde Whole year
3 Tiffany Wong Whole year
4 Linda Ebosie From 18 June 2025
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
----- End of picture text -----

– Corporate trustees names of the directors at the date the report was approved Director name Not applicable – A Rare Cause is a Charitable Incorporated Organisation and does not have corporate trustees.

Name of trustees holding title to property belonging to the charity

----- Start of picture text -----
Trustee name Dates acted if not for whole year
Not applicable – no assets are
held in the names of individual
trustees.
----- End of picture text -----

Funds held as custodian trustees on behalf of others

Description of the assets
held in this capacity
Not applicable – the charity does not act as custodian trustee
for other charities.
Name and objects of the
charity on whose behalf the
assets are held and how this
falls within the custodian
charity’s objects
Details of arrangements for
safe custody and
segregation of such assets
from the charity’s own
assets

Additional information (optional)

Names and addresses of advisers (Optional information)

----- Start of picture text -----
Type of Name Address
adviser
Bankers Wise Payments Ltd 1st Floor, Worship Square, 65 Clifton Street, London EC2A 4JE
Bankers CAF Bank Ltd (account opened 2026, after this reporting period)
Name of chief executive or names of senior staff members (Optional information)
None – the charity has no employees; activities are undertaken by trustees and volunteers.
----- End of picture text -----

Exemptions from disclosure

Reason for non-disclosure of key personnel details

Not applicable – no exemption from disclosure has been applied.

Other optional information

Further detail on the charity's activities and strategic priorities during the period is set out in the Trustees' Update Report (June 2026), available separately.

Declarations

The trustees declare that they have approved the trustees’ report above.

Signed on behalf of the charity’s trustees

----- Start of picture text -----
Signature(s)
Full name(s) Tiffany Wong
Position (eg Secretary
Secretary, Chair, etc)
Date
October 25 2026
----- End of picture text -----

A RARE CAUSE

Financial Statements For the year ended 31 December 2025

Registered number: 1198461

A RARE CAUSE CONTENTS FOR THE YEAR ENDED 31 DECEMBER 2025

CONTENTS
Legal and administrative information Page 1
Statement of financial activities Page 2
Balance sheet Page 3

A RARE CAUSE LEGAL AND ADMINISTRATIVE INFORMATION FOR THE YEAR ENDED 31 DECEMBER 2025

Trustees

Charity Registered Number - 1198461

Registered Office

6 The Green Burley In Wharfedale Ilkley West Yorkshire LS29 7FF

Accountants

Bloomfield’s Bloomfield Court 76 Factory Street West Atherton, Manchester M46 0EF

1

A RARE CAUSE STATEMENT OF FINANCIAL ACTIVITIES AND BALANCE SHEET FOR THE YEAR ENDED 31 DECEMBER 2025

Restricted
funds
Unrestricted
funds
2025
2025
£
£
INCOMING RESOURCES
Grants received
25,342
-
Transfers from/to Deferred Income
(22,965)
-

2,377
-
Fundraising
-
-
Donations
30
-
TOTAL INCOMING RESOURCES
2,407
-
RESOURCES EXPENDED
Direct Charitable Expenditure
Travel
1,499
-
Bank Charges
6
-
Grants Made
502
-
Accountancy & Secretarial
400
-
TOTAL RESOURCES EXPENDED
2,407
-
NET INCOMING / (OUTGOING)
RESOURCES BEFORE TAXATION
-
-
Taxation
-
-
NET MOVEMENT IN FUNDS
-
-
Fund balances at 1 April 2024
120
-
FUND BALANCES AT 31 March
2025
120
-
Total
funds
2025
£
25,342
(22,965)
2,377
-
30
2,407
1,499
6
502
400
2,407
-
-
-
120
120
Total
funds
2024
£
-
-
-
-
120



120
-
-
-
-
-
120
-
120
-
120

2

A RARE CAUSE STATEMENT OF FINANCIAL ACTIVITIES AND BALANCE SHEET FOR THE YEAR ENDED 31 DECEMBER 2025

CURRENT ASSETS
Cash and bank in hand
CREDITORS: Amounts falling due within one
year
Net current assets
TOTAL ASSETS LESS CURRENT
LIABILITIES
NET ASSETS
CHARITY FUNDS
Restricted funds
Unrestricted funds
2025
£
23,485
23,485
(23,365)
120
120
2024
£
£
120
120
-
120
120
120
120
-
120
£
120
120
-
120

The directors and trustees consider that the company is entitled to exemption from the requirement to have an audit under the provisions of S.480 of the Companies Act 2006.

No notice from the members under S.476 of the Companies Act 2006 requiring the company to have an audit has been deposited with the company.

The directors and trustees acknowledge their responsibility for ensuring that the company keeps accounting records which comply with S.386 of the Companies Act 2006, and for preparing accounts, which give a true and fair view of the state of the affairs of the company at 31[st ] December 2025 and of its net expenditure for the year then ended in accordance with the requirements of S.396, but which otherwise comply with the requirements of the Act relating to the accounts so far as applicable to the company.

The financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements were approved by the Trustees on 2026 and signed on their behalf, by: October 25,

Director

Date______2026 October 25,

3

6 The Green Ilkley LS29 7FF United Kingdom Registered charity in England & Wales Registration: 1198461

Charity commission

We believe independent auditors report is not required due to income level but audited accounts are attached and signed by trustee representative.

KR

Christian Hendriksz (Prof) Chief Community Impact Officer